Syntax score predicts clinical outcome in patients with three-vessel coronary artery disease undergoing percutaneous coronary intervention

Chinese Medical Journal

Volumn 124, Issue 5, 2011, Pages 704-709

  He, Ji Qiang ^a   Gao, Yue Chun ^a   Yu, Xian Peng ^a   Zhang, Xiao Ling ^a   Luo, Ya Wei ^a   Wu, Chang Yan ^a   Li, Yu ^a   Zhang, Wei Dong ^a   Chen, Fang ^a   Lü, Shu Zheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

3 vessel coronary artery disease; Percutaneous coronary intervention; Syntax score

Indexed keywords

RAPAMYCIN;

ACCURACY; ADULT; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYNTAX SCORE; THREE VESSEL CORONARY ARTERY DISEASE;

ADULT; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 79952506818     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.05.013     Document Type: Article

References (20)

1. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The Syntax score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005; 1: 219-227.
2. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981; 63: 285-299
3. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB, Loop FD, et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American college of cardiology/American heart association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal coronary angioplasty). Circulation 1988; 78: 486-502.
4. Ellis SG, Vandormael MG, Cowley MJ, Whitlow PL, Schneider JP, Topol EJ. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990; 82: 1193-1202.
5. Hamburger JN, Serruys PW, Scabra-Gomes R, Simon R, Koolen JJ, Fleck E, et al. Recanalization of total coronary occlusions using a laser guidewire (the European TOTAL Surveillance Study). Am J Cardiol 1997; 80: 1419-1423.
6. Iwakura K, Ito H, Ikushima M, Okamura A, Asano K, Kuroda T, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7.
7. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, Benslimane A, et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv 2000; 49: 274-283.
8. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronaryartery disease. N Engl J Med 2009; 360: 961-972.
9. Gyöngyösi M, Christ G, Lang I, Kreiner G, Sochor H, Probst P, et al. Two-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study. JACC Cardiovasc Interv 2009; 2: 718-727.
10. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. Circulation 2001; 103: 3019-3041.
11. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.
12. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.
13. Kukreja N, Onuma Y, Garcia-Garcia HM, Daemen J, van Domburg R, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000-5). Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients. Am J Cardiol 2009; 103: 203-211.
14. Daemen J, van Twisk PH, Kukreja N, van Domburg RT, Boersma E, de Jaegere P, et al. The relative safety and efficacy of bare-metal and drug-eluting stents in low and high-risk patient subsets. An epidemiological analysis of three sequential cohorts of consecutive all comers (n=6129). EuroIntervention 2009; 4: 464-474.
15. Ross MJ, Herrmann HC, Moliterno DJ, Blankenship JC, Demopoulos L, DiBattiste PM, et al. Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial. J Am Coll Cardiol 2003; 42: 981-988.
16. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet 2009; 373: 1190-1197.
17. Benedetto U, Melina G, Angeloni E, Refice S, Roscitano A, Fiorani B, et al. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease: a meta-analysis on 24 268 patients. Eur J Cardiothorac Surg 2009; 36: 611-615.
18. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 2008; 117: 2079-2086.
19. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, et al. Drug-eluting stents vs.coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358: 331-341.
20. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, vanden Brand MJ, et al. Cyphering the complexity of coronary artery disease using the Syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007; 99: 1072-1081.